NAS:APYX (USA)
Business Description
Apyx Medical Corp
NAICS : 339112
SIC : 3841
5115 Ulmerton Road, Clearwater, FL, USA, 33760
Description
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians a unique ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of revenue.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 25.02 | |||||
| Equity-to-Asset | 0.77 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.05 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 11.4 | |||||
| Beneish M-Score | -2.64 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 43 | |||||
| 3-Year EPS without NRI Growth Rate | -11.2 | |||||
| 3-Year FCF Growth Rate | 19.3 | |||||
| 3-Year Book Growth Rate | -15.5 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 15.86 | |||||
| 9-Day RSI | 28.03 | |||||
| 14-Day RSI | 37.03 | |||||
| 6-1 Month Momentum % | -24.24 | |||||
| 12-1 Month Momentum % | -27.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.45 | |||||
| Quick Ratio | 3.6 | |||||
| Cash Ratio | 1.77 | |||||
| Days Inventory | 157.73 | |||||
| Days Sales Outstanding | 79.71 | |||||
| Days Payable | 61.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.7 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 68.7 | |||||
| Operating Margin % | -34.03 | |||||
| Net Margin % | -34.21 | |||||
| ROE % | -33.72 | |||||
| ROA % | -26.78 | |||||
| ROIC % | -64.11 | |||||
| ROC (Joel Greenblatt) % | -105.74 | |||||
| ROCE % | -32 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.71 | |||||
| PB Ratio | 5.33 | |||||
| Price-to-Tangible-Book | 5.31 | |||||
| EV-to-EBIT | -13.01 | |||||
| EV-to-EBITDA | -13.74 | |||||
| EV-to-Revenue | 4.35 | |||||
| EV-to-FCF | -15.42 | |||||
| Price-to-Median-PS-Value | 1.09 | |||||
| Price-to-Net-Current-Asset-Value | 6.6 | |||||
| Price-to-Net-Cash | 37.16 | |||||
| Earnings Yield (Greenblatt) % | -7.69 | |||||
| Forward Rate of Return (Yacktman) % | 14.28 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NAS:APYX
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 51.44 | ||
| EPS (TTM) ($) | -0.51 | ||
| Beta | 1.58 | ||
| Volatility % | 113.67 | ||
| 14-Day RSI | 37.03 | ||
| 14-Day ATR ($) | 0.786701 | ||
| 20-Day SMA ($) | 9.33725 | ||
| 12-1 Month Momentum % | -27.88 | ||
| 52-Week Range ($) | 3.01 - 17.5 | ||
| Shares Outstanding (Mil) | 34.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Apyx Medical Corp Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||